---
figid: PMC9553391__OMCL2022-8965903.008
pmcid: PMC9553391
image_filename: OMCL2022-8965903.008.jpg
figure_link: /pmc/articles/PMC9553391/figure/fig8/
number: Figure 8
figure_title: ''
caption: Schematic diagram of anlo-induced PDL1, IFN-α/β/γ, and CXCL2 expression in
  mouse CRC cells. Anlo increased ROS, leading to activate JNK/AP-1/interferon signaling
  pathway. Meanwhile, AP-1/interferons contributed to the upregulation of PDL1, INF-α/β/γ,
  and CXCL2.
article_title: Anlotinib Benefits the αPDL1 Immunotherapy by Activating ROS/JNK/AP-1
  Pathway to Upregulate PDL1 Expression in Colorectal Cancer.
citation: Bixian Luo, et al. Oxid Med Cell Longev. 2022;2022:8965903.
year: '2022'

doi: 10.1155/2022/8965903
journal_title: Oxidative Medicine and Cellular Longevity
journal_nlm_ta: Oxid Med Cell Longev
publisher_name: Hindawi

keywords:
---
